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Singleton-Merten syndrome (SMS) is an infrequently described autosomal-dominant disorder characterized by early and extreme aortic
and valvular calcification, dental anomalies (early-onset periodontitis and root resorption), osteopenia, and acro-osteolysis. To deter-
mine the molecular etiology of this disease, we performed whole-exome sequencing and targeted Sanger sequencing. We identified a
common missense mutation, c.2465G>A (p.Arg822Gln), in interferon induced with helicase C domain 1 (IFIH1, encoding melanoma
differentiation-associated protein 5 [MDA5]) in four SMS subjects from two families and a simplex case. IFIH1 has been linked to a num-
ber of autoimmune disorders, including Aicardi-Goutie`res syndrome. Immunohistochemistry demonstrated the localization ofMDA5 in
all affected target tissues. In vitro functional analysis revealed that the IFIH1 c.2465G>A mutation enhanced MDA5 function in inter-
feron beta induction. Interferon signature genes were upregulated in SMS individuals’ blood and dental cells. Our data identify a gain-of-
function IFIH1 mutation as causing SMS and leading to early arterial calcification and dental inflammation and resorption.Singleton-Merten syndrome (SMS [MIM 182250]) is an
infrequently described entity characterized by abnormal-
ities of blood vessels, teeth, and bone.1,2 Calcifications of
the aorta and aortic and mitral valves occur in childhood
or puberty (Figures 1A and 1B and Movies S1 and S2) and
can lead to early demise. Dental findings include a delay
in primary tooth exfoliation and permanent tooth erup-
tion, truncated tooth root formation, early-onset peri-
odontal disease, and severe root and alveolar bone
resorption associated with dysregulated mineralization3
leading to tooth loss (Figure 1C). Osteoporosis (either
generalized or limited to distal extremities), distal-limb
osteolysis, widened medullary cavities, and easy tearing
of tendons from bone are core osseous manifestations
(Figure 1D). Less common features are an unusual face
(high anterior hair line, broad forehead, smooth philtrum,
and thin upper vermillion), generalized muscle weakness,
psoriasis, early-onset glaucoma, and recurrent infections.
SMS follows an autosomal-dominant pattern of inheri-
tance andmanifests with variable interfamilial and intrafa-
milial phenotypes.2 The cause is not known, although
altered immunological functioning has been suggested.2
In an effort to elucidate the molecular basis for SMS,
we undertook a broader approach by whole-exome
sequencing (WES). We obtained blood samples and pedi-
grees after acquiring written informed consent from each
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The Americfrom the ethical committees of the University of Amster-
dam and fromMuenster University Hospital. Five SMS sub-
jects from three families and four unaffected relatives were
included in theWES study (Figure 2A). The clinical features
of these SMS-affected families were previously reported by
Feigenbaum et al.2 DNA (1 mg) was fragmented by sonifica-
tion (Covaris), end repaired, and adaptor ligated with the
inclusion of sample index barcodes. After size selection,
the library was subjected to enrichment with the SeqCap
EZ Human Exome Library v.2.0 (Roche NimbleGen). The
enriched library was subsequently sequenced on an
Illumina HiSeq 2000 sequencing instrument with a
paired-end 2 3 100 bp protocol. For the nine exomes,
the sequence output was on average 90.3 million reads,
and 85% were uniquely mapped. For the 203, 303, and
mean coverage of target sequences, we obtained average
values of 94%, 90%, and 102%, respectively. For data anal-
ysis, the Varbank pipeline v.2.3 and filter interface were
used. Primary data were filtered according to signal purity
by the Illumina Realtime Analysis software v.1.8. Subse-
quently, the reads were mapped to the human genome
reference (UCSC Genome Browser hg19) with the Bur-
rows-Wheeler Aligner.4 The Genome Analysis Toolkit
v.1.65 was used to mark duplicated reads, perform local re-
alignments around short indels, recalibrate the base and
variant quality scores, and call SNPs and short indels.
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Figure 1. Core Phenotypic Features of SMS
(A) Postmortem heart specimen of subject IV-1 from family 1. Note the widespread, extremely marked calcifications in the outflow tract
of the left ventricle, aortic valve, and ascending aorta.
(B) A chest X-ray of subject II-2 from family 3 at 12 years shows aortic calcification (for cardiac angiograms from subject II-1 from family
2, see Movies S1 and S2).
(C) Progressive dental abnormalities observed in subject II-3 from family 2 over a 6-year period. Normal formation of root structures and
secondary dentition are shown at 7 years with rapid progressive development of periodontitis and root resorption.
(D) Hand X-ray of subject II-2 from family 3 at age 12 years. Note the marked distal osteolysis and wide medullary cavities.
Images in (A), (B), (D), and part of (C) were reproduced with permission from Feigenbaum et al.2Genomics were applied to detect protein changes, affected
donor and acceptor splice sites, and overlaps with known
variants. Acceptor and donor splice-site mutations were
analyzed with a Maximum Entropy model.6 Filtering of
variants was performed as described in Table S1.
Given the observed autosomal-dominant inheritance
pattern, we assumed a de novo variant in the simplex
case (family 3). WES data analysis identified putative dele-
terious mutations in two genes: SPECC1L (MIM 614140)
and IFIH1 (interferon induced with helicase C domain 1
[MIM 606951]; RefSeq accession number NM_022168.3;
Table S1). Additional analyses showed that the IFIH1
missense mutation, c.2465G>A (p.Arg822Gln), co-segre-
gated with the disorder (Figure 2A). Sanger sequencing in
17 additional members of family 1 validated the IFIH1
variant in all affected subjects and demonstrated segrega-
tion in all members with dental anomalies, except in one
person (Figures 2A and 2B). One individual with only
psoriasis also carried the mutation, whereas three other
subjects with only psoriasis harbored no mutation. No
unaffected individual carried the variant. The IFIH1
c.2465G>A variant has been reported as a single-nucleo-
tide variation (rs376048533) in 1 of 6,517 individuals
sampled in the NHLBI Exome Sequencing Project (ESP)
Exome Variant Server cohort populations. The variant is
listed in the Exome Aggregation Consortium Browser
with an allele frequency of 0.00002481.
Melanoma-differentiation-associated protein 5 (MDA5),
encoded by IFIH1, is a member of the RIG-I-like receptor
family and functions as a cytoplasmic pattern-recognition
receptor recognizing virus double-stranded RNA (dsRNA)
and secreted bacterial nucleic acids.7 To determine
whether the localization pattern of MDA5 correlated
with affected tissues in SMS individuals, we performed
fluorescent immunohistochemistry on cryosections from
human heart, skin, and cartilage tissues. MDA5 was de-276 The American Journal of Human Genetics 96, 275–282, Februarytected in cardiac myocytes, epidermis, and cartilage chon-
drocytes (Figure 3A). For analysis of MDA5 localization in
developing teeth, paraffin-embedded 28-day postnatal
mouse mandibles were fixed and demineralized prior to
immunohistochemistry. MDA5 was found to be localized
in ameloblasts, odontoblasts, the periodontal ligament,
and active osteoblasts at the surface of the alveolar bone
(Figure 3B). These results indicate that MDA5 localized to
all target tissues altered in SMS.
The SMS-associated amino acid substitution we identi-
fied is located in the HEL2 domain, one of the two
conserved core helicase domains (Figure 4A), at an evolu-
tionary conserved sequence motif (Figure 4B). The crystal
structure of MDA5 shows that this motif is close to the
bound ATP analog at the ATPase binding site (Figure 4C).
It was suggested that this conserved sequence motif medi-
ates conformational changes triggered by ATP binding to
create a high-affinity nucleic acid binding site and thus
leads to unwinding.8 Such a conformational change was
shown later for a p.Gly821Ser altered MDA5, which re-
sulted in a gain of function and led to spontaneously devel-
oped lupus-like autoimmune symptoms in a mouse
model.9
To investigate the effect of the p.Arg822Gln substitution
on MDA5 function, we cloned, sequenced, and inserted
the IFIH1 open reading frames from one SMS individual
and one healthy individual into expression vectors (SMS-
IFIH1 and wild-type-IFIH1, respectively). Because MDA5
p.Arg822Gln is the only alteration in common between
all SMS-affected individuals and non-affected individuals,
we corrected c.2465G>A in the SMS-IFIH1 vector back to
normal c.2465A>G (DSMS-IFIH1 vector) to see whether
this single amino acid change can functionally and
dominantly affect MDA5 function. We used HEK293T
cells, with the lowest endogenous IFIH1 expression levels
(Figure 5A), to overexpress MDA5. After transfection of5, 2015
Figure 2. Pedigrees of Studied SMS-
Affected Families and the Identified
Disease-Causing Germline Mutation
c.2625G>A in IFIH1
(A) Families 1 and 2 show an autosomal-
dominant mode of inheritance. In family
3, the affected individual is a simplex case
identified as having a de novo mutation.
Details of the phenotype in these families
are available in Feigenbaum et al.2
(B) Sanger sequencing electropherograms
of two probands (IV-1 and V-1 from fam-
ily 1) and one unaffected family member
(IV-2) confirm the IFIH1 c.2625G>A
(p.Arg822Gln) mutation.the wild-type-IFIH1 vector, IFNB1 (interferon, beta 1, fibro-
blast [MIM 147640]) expression was increased in a dose-
dependent manner in HEK293T cells (Figures 5B and 5C).
Overexpression of the SMS-IFIH1 vector led to approxi-
mately 203 more IFNB1 expression in HEK293T cells ex-
pressing the SMS-IFIH1 vector than in cells expressing
wild-type IFIH1 (Figure 5C). Overexpression of the DSMS-
IFIH1 and wild-type-IFIH1 vectors resulted in similar
amounts of IFNB1 expression, thus indicating that the
p.Arg822Gln substitution is functional and dominant in
controlling b-interferon production (Figure 5C). Given
that Arg822 is located in one of the motifs implicated in
nucleotide binding,10–12 we next tested whether the
p.Arg822Gln substitution affects MDA5 function in
inducing b-interferon production in cells after non-self-
RNA stimulation. We established HEK293T cell lines stably
overexpressing the SMS-IFIH1 or DSMS-IFIH1 vector by us-The American Journal of Human Ging a lentiviral delivery system and
challenged them with the dsRNA
analog poly(I:C). As expected, SMS-
IFIH1HEK293Tcells had a higher level
of IFNB1 expression than did DSMS-
IFIH1 HEK293T cells after poly(I:C)
stimulation (Figure 5D). These data
indicate that the SMS-IFIH1 vector is
hyperactive to non-self-dsRNA. In
agreement with the elevated expres-
sion level of IFNB1 by SMS-IFIH1
signaling, there was also higher
expression of interferon signature
genes (ISGs; IFI27 [MIM 600009],
IFI44L [MIM 613975], IFIT1 [MIM
147690], ISG15 [MIM 147571],
RSG15, RSAD2 [MIM 607810], and
SIGLEC1) in whole-blood samples
from SMS individuals as measured
by quantitative real-time PCR
(Figure 6A). Similar results were ob-
tained with isolated dental enamel or-
gan epithelial cells from extracted SMS
and control third molars (Figure 6B).
Compared with that of healthy indi-viduals, the interferon score of SMS individuals was signif-
icantly altered (p < 0.0001 by unpaired t test; Figure 6C).
IFIH1 has been linked to a number of autoimmune dis-
eases. Genome-wide association studies (GWASs) have
associated IFIH1 SNPs with psoriasis risk13,14 and with sys-
temic lupus erythematosus and dilated cardiomyopa-
thy.15,16 RNF114 (MIM 612451), a regulator of RIG-I and
MDA5 signaling, has also been identified as a psoriasis
susceptibility gene.17 Genetic screens have also identified
a number of IFIH1 SNPs, which are associated with
resistance to type 1 diabetes due to MDA5 loss of func-
tion.18–20 Six IFIH1 point mutations, affecting the coding
helicase domains, have been associated with a spectrum
of neurological phenotypes, including Aicardi-Goutie`res
syndrome (AGS [MIM 225750]), all showing an upregu-
lated type I interferon response.21,22 On the basis of a
similar gain-of-function IFIH1 mutation, SMS is allelicenetics 96, 275–282, February 5, 2015 277
Figure 3. Immunohistochemistry of MDA5 in Human Heart and
Skin and Murine Dental Tissues
(A) MDA5 localization in heart, skin, and cartilage. H&E staining
shows general morphology (i, iv, vii, x, and xiii), and von Kossa
278 The American Journal of Human Genetics 96, 275–282, Februarywith AGS. However, the SMS phenotype differs substan-
tially from the AGS phenotype. The core SMS findings of
aortic calcification, dental anomalies, widened medullary
cavities, osteoporosis, and acro-osteolysis have not been re-
ported in AGS individuals, and none of our SMS cohort
demonstrated microcephaly, intracranial calcification
visible on plain skull X-rays, or significant neurological
or developmental manifestations. Glaucoma occurs at
low frequency in both entities though,2,23 and a specific
search for minimal manifestations of the above signs in
both entities has not been undertaken. Additional studies
might reveal a continuum of features between AGS and
SMS. Alternatively, the p.Arg822Gln substitution might
specifically alter MDA5 function and lead to SMS, whereas
other IFIH1 mutations cause related but distinct effects on
protein function and lead to AGS and related neurological
phenotypes. Because type I interferon production is
elevated in both syndromes, the latter is more reasonable.
Conformational changes by different amino acid substitu-
tions could make MDA5 distinctly active to cytoplasmic
dsRNA from self-RNA as well as to exogenous pathogens.
The p.Arg822Gln substitution identified in this study
was previously reported in the ESP Exome Variant Server
in a single individual with cardiac and pulmonary pheno-
types. It could be that this individual demonstratesstaining demonstrates the presence or absence of hydroxyapatite
deposits (ii, v, and viii). MDA5 immunolabeling (iii, vi, ix, xii,
and xv) and control immunolabeling with no primary antibody
(xi and xiv) are also shown. MDA5 is localized in cardiac myocytes
(iii, vi, and ix), the epidermis (xii), and chondrocyctes of the carti-
lage (xv). Immunofluorescence signal of MDA5 was labeled with
rabbit anti-MDA5 antibody (pAb AT113, Enzo LifeScience) at a
1:200 dilution and Cy3-conjugated secondary antibodies (red).
DAPI was used to stain nuclei (blue). Autofluorescence of matrix
structures is shown in green. The control individual is shown in
(i)–(iii), the SMS individual’s mitral valve is shown in (iv)–(vi),
and the SMS individual’s aortic valve is shown in (vii)–(ix).
(B) MDA5 localization in mouse 28-day and 7-day postnatal teeth.
The rabbit anti-MDA5 antibody (1:200 dilution) was incubated for
1 hr, and the pre-diluted secondary antibody was subsequently
incubated with the SuperPicTure Polymer Dectection Kit (Invitro-
gen) for 30 min at room temperature and visualized with 3-30
tetrachloride diaminobenzidine (DAB) chromogen (brown) for
1–2 min at room temperature. For the negative controls, BSA
replaced the primary antibody step in the protocol. Low magnifi-
cation of the entire erupted tooth with root structure and peri-
odontal ligament is shown in (i) and (v). Labeled ameloblasts (ii
and iv) and odontoblasts (ii and iii) show intracellular labeling
and within-odontoblast cell processes (iii, arrow) and ameloblast
Tomes’ processes (iv, arrow); no staining is seen in the enamel (ii
and iv), dentin (i–iii), or cementum lining the root surface (vi, ar-
row). Active osteoblasts at the surface of the alveolar bone (v),
junctional and gingival epithelium (vi) of the oral epithelium, fili-
form papilla of the tongue (viii), and skeletal muscle of the tongue
(viii) and craniofacial complex (x) express high levels of MDA5.
Proliferating chondrocytes in the cartilage (ix) are less intensively
stained. The lamina propria of the tongue is negative (vii), as is the
negative control (vii). Abbreviations are as follows: E, enamel; D,
dentin; Od, odontoblast; P, pulp; AvC, alveolar crest; PDL, peri-
odontal ligament; DEJ, dentin enamel junction; AvB, alveolar
bone; C, cementum; JE, junctional epithelium; GE, gingival
epithelium; K, keratinized layer; FP, filiform papilla; LP, lamina
propria; SM, skeletal muscle; and PC, proliferating chondrocyte.
5, 2015
Figure 4. MDA5 Structure Highlighting the Location of the SMS
p.Arg822Gln Substitution
(A) Color-coded schematic of theMDA5 structure shows the N-ter-
minal region with two tandem caspase activation and recruitment
domains (CARDs), central DExD/H box RNA helicase domains
(HEL1 andHEL2), a helicase-insert domain (HEL2i), and a C-termi-
nal domain (CTD), also called the regulatory or repressor domain.
The latter two domains are responsible for recognizing dsRNA. The
SMS p.Arg822Gln substitution is located near the HEL2 domain
termination.
(B) Partial amino acid sequence alignment of humanMDA5; repre-
sentative orthologs show conservation of the residue altered
in SMS. Multiple alignments of homologous MDA5 sequence
stretches within the helicase CTD for different organisms are
compared with human RIG-1, Hef-helicase from the Archaea spe-
cies Pyrococcus furiosus, and the hepatitis C virus (HCV) helicase.
The box indicates the region conserved among the helicase se-
quences, and the arginine altered in SMS is highlighted in pink.
Note: this amino acid is highly conserved across evolution. Species
are as follows: pig, Sus scofus; bovine, Bos taurus; dog, Canis famil-
iaris; mouse, Mus musculus; chicken, Gallus gallus; fish, Danio rerio
(zebragish); frog, Xenopus laevis (African clawed frog); and worm,
Caenorhabditis elegans.
(C) 3D structure of the humanMDA5 helicase region in schematic
representation (PDB code 4GL2). Note: the N-terminal 2-CARD re-
The Americunrecognized manifestations of SMS or is asymptomatic,
as occurred in two members of a recently reported IFIH1-
mutation-positive family despite the presence of high sus-
tained induction of interferon signaling.21 We also note
significant phenotypic variation present in the SMS-
affected family 1. This clinical variability is most likely
explainable by modifying genetic factors, epigenetic fac-
tors, and exogenous influences such as exposure to
different pathogens. The rapid alveolar bone loss in SMS
individuals is one of the key characteristics of aggressive
periodontitis. Periodontitis is typically caused by oral path-
ogenic bacteria.We hypothesize that the p.Arg822Gln sub-
stitution inMDA5 dysregulates host immune response as a
result of hyperactivity to pathogenic viruses or bacteria
and/or aberrant cross-talk with other pattern-recognition
receptors. Furthermore, expression of the c.2465G>A
mutant IFIH1 during development might alter the integ-
rity of mineralized structures of the tooth.
Taken together, our data demonstrate that the MDA5
gain-of-function substitution p.Arg822Gln causes the
autosomal-dominant disorder SMS through dysregulation
of the human innate immune response. The altered
MDA5 triggers type I interferon production, which is
increased in SMS individuals and which returns to baseline
with correction of themissense mutation. This heightened
inflammatory state most likely leads to early-onset aggres-
sive periodontitis and abnormal root resorption. We hy-
pothesize a similar process in cardiac and vascular tissue.
Further studies are needed to elucidate the cellular and
molecular mechanisms of this SMS-associated MDA5 sub-
stitution in contribution to dysregulation of the innate im-
mune response and subsequent disease.Supplemental Data
Supplemental Data include two tables and two movies and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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Figure 5. The p.Arg822Gln Substitution
in MDA5 Enhances IFNB1 Induction
The coding region of human MDA5 was
amplified from dental cells from one SMS
individual (SMS-IFIH1) and one unaffected
individual (IFIH1) and cloned into
pcDNA3.1 (Life Technologies) and pCDH-
CMV-MCS-EF1-copGFP (System Biosci-
ences). SMS-IFIH1 c.2465A>G was cor-
rected back to c.2465G>A (DSMS-IFIH1)
with the GENEART Site-Directed Mutagen-
esis System according to the manual in-
structions. The primer sets are detailed in
Table S2. For lentivirus generation, recom-
binant pCDH vector and package vectors
were transfected into HEK293T cells.
Concentrated virus with SMS-IFIH1,
DSMS-IFIH1, or empty vector alone was
used to infect HEK293T cells for establish-
ing cell lines. Cells were then sorted by
flow cytometry at the same fluorescence
identity.
(A) IFIH1 was expressed at very low levels
in HEK293T cells. Relative expression of
endogenous IFIH1 in different types of cells
was analyzed by real-time PCR in triplicates
and normalized to GAPDH.
(B) IFNB1 was dose-dependently induced
in HEK293T cells by transient transfection
of IFIH1. HEK293T cells in 24-well plates
were transfected with pcDNA3-IFIH1 at
the indicated concentration for 24 hr. Rela-
tive expression of IFIH1 and IFNB1 was
analyzed by real-time PCR in triplicates
and normalized to cells transfected with
empty vector.
(C) MDA5 with the p.Arg822Gln substitu-
tion induced a higher level of IFNB1 in
HEK293T cells. HEK293T cells in 24-well
plates were transfected with pcDNA3-IFIH1 (IFIH1), pcDNA3-IFIH1 (SMS-IFIH1), and pcDNA3-DSMS-IFIH1 (DSMS-IFIH1) at the indicated
concentration for 24 hr. IFIH1 and IFNB1 mRNA was analyzed by real-time PCR in triplicates and normalized to HEK293T cells trans-
fected with empty vector.
(D) ElevatedmRNA level of IFNB1 in SMS-IFIH1 overexpressing HEK293Tcells after stimulation with poly(I:C). HEK293T cells with SMS-
IFIH1, DSMS-IFIH1, or empty vector (vector) were seeded in 24-well plates and transfected with the indicated amount of poly(I:C) for
24 hr. Relative expression of IFIH1 and IFNB1 mRNA was analyzed by real-time PCR in triplicates and normalized to unstimulated
HEK293T cells with empty vector. **p < 0.01 by two-tailed Student’s t test, indicating a significant difference between the SMS-IFIH1
group and the DSMS-IFIH1 group.
Error bars represent the SD.thank Johannes Roth, Helmut Wittkowski, and Katazyrna Barczik
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affected individuals.
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Figure 6. Effects of the SMS-Associated MDA5 Amino Acid Sub-
stitution on the Induction of ISGs
(A) Quantitative analysis of ISGs in whole-blood samples from
four SMS family members. The expression of IFI27, IFI44L, IFIT1,
ISG15, RSG15, RSAD2, and SIGLEC1 was analyzed by qPCR in
three technical replicates. The relative expression of each gene
in SMS blood samples was normalized to controls and is repre-
sented as themean5 SD. Numbers in parentheses refer to the pro-
band’s age (in years) at sampling (left) and the interferon score
calculated from the median of relative change for the tested ISGs
(right).
(B) Relative expression of ISGs in SMS versus control primary
dental enamel organ epithelial (EOE) cells. Values represent the
mean 5 SD from two independent experiments, each of which
had three technical replicates (n¼ 6). p values< 0.05 by two-tailed
Student’s t test. Note: SIGLEC1 was not detected in the EOE cells.
(C) The interferon score of blood samples in affected (n ¼ 4) and
unaffected (n ¼ 29) family members was calculated as the median
of relative change for the tested ISGs. The red bar indicates theme-
dian interferon score in mutation-positive individuals. The inter-
feron score was significantly higher in the SMS individuals than
in the control individuals (unpaired t test p < 0.0001).
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